Reduced expression of MYO18B, a candidate tumor‐suppressor gene on chromosome arm 22q, in ovarian cancer
- 2 June 2004
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 112 (1), 150-154
- https://doi.org/10.1002/ijc.20339
Abstract
Allelic imbalance on chromosome arm 22q has been detected in 50–70% of ovarian cancers, suggesting the presence of a tumor‐suppressor gene on this chromosome arm that is involved in ovarian carcinogenesis. Recently, we isolated a candidate tumor‐suppressor gene, MYO18B, at 22q12.1, which is deleted, mutated and hypermethylated in approximately 50% of lung cancers. In our study, we analyzed genetic and epigenetic alterations of the MYO18B gene in ovarian cancers. Missense MYO18B mutations were detected in 1 of 4 (25%) ovarian cancer cell lines and in 1 of 17 (5.9%) primary ovarian cancers. MYO18B expression was reduced in all 4 ovarian cancer cell lines and in 12 of 17 (71%) of primary ovarian cancers. MYO18B expression was restored by treatment with 5‐aza‐2′‐deoxycytidine and/or trichostatin A in 3 of 4 cell lines with reduced MYO18B expression, and hypermethylation of the promoter CpG island for MYO18B was observed in 2 of these 3 cell lines. Its hypermethylation was also observed in 2 of 15 (13%) primary ovarian cancers. Thus, it was indicated that MYO18B expression is reduced in a considerable fraction of ovarian cancers by several mechanisms, including hypermethylation, while the MYO18B gene is mutated in a small subset of ovarian cancers. The present results suggest that MYO18B alterations, including both epigenetic and genetic alterations, play an important role in ovarian carcinogenesis.Keywords
This publication has 18 references indexed in Scilit:
- Correlation between histone acetylation and expression of the MYO18B gene in human lung cancer cellsGenes, Chromosomes and Cancer, 2004
- A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumorsCancer, 2003
- Specific Keynote: Hereditary Ovarian Cancer: What We KnowGynecologic Oncology, 2003
- Cytogenetics and molecular genetics of ovarian cancerAmerican Journal of Medical Genetics, 2002
- Refinement of an ovarian cancer tumour suppressor gene locus on chromosome arm 22q and mutation analysis ofCYP2D6,SREBP2 andNAGAInternational Journal of Cancer, 2000
- Two regions of homozygous deletion clusters at chromosome band 9p21 in human lung cancerGenes, Chromosomes and Cancer, 2000
- Allelic imbalance and mutations of thePTEN gene in ovarian cancerInternational Journal of Cancer, 2000
- Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomasGenes, Chromosomes and Cancer, 1997
- Chromosome aberrations in 35 primary ovarian carcinomasGenes, Chromosomes and Cancer, 1992
- Serial propagation of human ovarian surface epithelium in tissue cultureJournal of Cellular Physiology, 1988